BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 27, 2005
View Archived Issues
TKT Absorbed For $1.6B As Shire Fattens Pipeline
In what could be the largest acquisition of 2005 - and certainly the largest so far - Shire Pharmaceuticals Group plc has nabbed Transkaryotic Therapies Inc. in a deal worth $1.6 billion. (BioWorld International)
Read More
£32.8M For Alizyme Earmarked For Renzapride, Cetilistat Work
Read More
Blocking Toxins Could Defeat Bacterial Antibiotic Resistance
Read More
Genmab Moves Zanolimumab Into Lymphoma Pivotal Study
Read More
Tight Agrobiotech Rulings Provoke German Lawsuit
Read More
Cash Squeeze Could Hamper Finnish Personalized Medicine
Read More
Microdosing Guidelines From FDA Might Reduce Time, Waste
Read More
Europe Pressures Syngenta On Testing, Containing Bt10
Read More
Other News To Note
Read More